King Pharmaceuticals, Inc. Announces Intent to Voluntarily Delist From the New York Stock Exchange

02/08/11 BRISTOL, TN--(Marketwire - February 8, 2011) - King Pharmaceuticals, Inc. ( NYSE : KG ) (the "Company") announced today that it has submitted written notice to the New York Stock Exchange (the "NYSE") of its intention to voluntarily delist its common stock, no par value, from the NYSE. The Company intends to file a Form 25 with the Securities and Exchange Commission (the "SEC") on February 18 ...

+

-

 

King Pharmaceuticals, Inc. Announces Intent to Voluntarily Delist From the New York Stock Exchange

02/08/11 BRISTOL, TN--(Marketwire - 02/08/11) - King Pharmaceuticals, Inc. (NYSE: KG - News ) (the "Company") announced today that it has submitted written notice to the New York Stock Exchange (the "NYSE") of its intention to voluntarily delist its common stock, no par value, from the NYSE. The Company intends to file a Form 25 with the Securities and Exchange Commission (the "SEC") on February 18, 2011 ...

+

-

 

Pfizer merger sends stock price higher

03/02/11 Pfizer Inc. briefly hit a one-year high Tuesday on the New York Stock Exchange , one day after completing a $3.6 billion merger with King Pharmaceuticals Inc. and announcing that a breakthrough drug had received regulatory approval in Europe.

+

-